Clinical studies recruiting near Chandler

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Eli Lilly and Company · NCT07218380 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Ironwood Physicians P.C. dba Ironwood Cancer and Research Ce · Pfizer · NCT07028853 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Ironwood Cancer & Research Centers-Research ( Site 0054) · Merck Sharp & Dohme LLC · NCT06393374 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · TrialSphere · Kallyope Inc. · NCT07674654 Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
NA · Arizona Liver Health · Perspectum · NCT04054310 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · TrialSphere Corp, Merz Investigational Site #0010513 · Merz Therapeutics GmbH · NCT07018700 SELUTION4BTK Trial
NA · Chandler Regional Medical Center · M.A. Med Alliance S.A. · NCT05055297 A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · Arizona State Urological Research Institute, LLC ("ASURI") · UroGen Pharma Ltd. · NCT06774131 Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Ca
Phase 3 · Arizona Clinical Trials · Amgen · NCT07575399 Study of the Use of Orthopulse Photobiomodulation
NA · Private Practice · Biolux Technology GmbH · NCT05650359 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06480383 Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
Phase N/A · New Horizons Clinical Trials · Aspira Women's Health · NCT05245695 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Ironwood Cancer & Res Ctr /ID# 262446 · AbbVie · NCT04928846 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Ironwood Cancer & Research Centers · Pfizer · NCT06629779 A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Phase N/A · Chandler Clinical Trials - Site Number: 840106 · Sanofi · NCT07556159 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · Ironwood Cancer & Research Centers ( Site 0204) · Merck Sharp & Dohme LLC · NCT06890884 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site US026 · Incyte Corporation · NCT07522073 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Phase 3 · Ironwood Cancer and Research Centers Chandler Ii · BeOne Medicines · NCT07492641 A Study of Brenipatide in Participants With Opioid Use Disorder
Phase 2 · Eli Lilly and Company · NCT07420283 A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Phase 2 · AARA Clinical Research - Arizona Arthritis & Rheumatology As · Merck Sharp & Dohme LLC · NCT07133633 Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants
Phase 1 · Arizona Clinical Trials · Institut de Recherches Internationales Servier (I.R.I.S.) · NCT07250633 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Phase 3 · TrialSphere Corp, Merz Investigational Site #0010513 · Merz Therapeutics GmbH · NCT07018713 A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participant
Phase 2 · The Institute for Liver Health II dba Arizona Clinical Trial · Eli Lilly and Company · NCT07589608 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants Wi
Phase 3 · Research Site · AstraZeneca · NCT05211895 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Eli Lilly and Company · NCT06119581 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 1-13H98LK9 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Al
Phase 3 · Chandler Clinical Trials, LLC · Bristol-Myers Squibb · NCT07011745

Look up another city

Look up another condition